Much progress has been made in understanding the pathogenesis of early inflammatory arthritis and in diagnosing and treating this disease, mainly through detection of the presence of anti-citrullinated protein antibodies and early implementation of combination therapy. However, early inflammatory arthritis still presents a challenge to clinicians in terms of individual patient prognosis, an improvement in which might facilitate earlier and more personalized therapeutic intervention and achieve increased rates of remission.
- Dirkjan van Schaardenburg
- Ben A. C. Dijkmans